A detailed history of Canton Hathaway, LLC transactions in Amgen Inc stock. As of the latest transaction made, Canton Hathaway, LLC holds 215 shares of AMGN stock, worth $68,632. This represents 0.02% of its overall portfolio holdings.

Number of Shares
215
Previous 215 -0.0%
Holding current value
$68,632
Previous $61,000 9.84%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 06, 2022

SELL
$198.88 - $227.6 $2.25 Million - $2.58 Million
-11,326 Reduced 98.14%
215 $48,000
Q3 2021

Oct 14, 2021

SELL
$212.27 - $248.7 $451,073 - $528,487
-2,125 Reduced 15.55%
11,541 $2.45 Million
Q2 2021

Jul 08, 2021

BUY
$233.58 - $259.14 $109,549 - $121,536
469 Added 3.55%
13,666 $3.33 Million
Q1 2021

Apr 14, 2021

BUY
$221.91 - $258.6 $32,620 - $38,014
147 Added 1.13%
13,197 $3.28 Million
Q4 2020

Feb 03, 2021

BUY
$216.38 - $257.67 $62,966 - $74,981
291 Added 2.28%
13,050 $3 Million
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $112,632 - $125,256
480 Added 3.91%
12,759 $3.24 Million
Q2 2020

Jul 27, 2020

BUY
$197.81 - $242.74 $138,467 - $169,918
700 Added 6.05%
12,279 $2.9 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $190,258 - $252,334
-1,044 Reduced 8.27%
11,579 $2.35 Million
Q4 2019

Jan 10, 2020

BUY
$189.21 - $243.2 $116,553 - $149,811
616 Added 5.13%
12,623 $3.04 Million
Q3 2019

Oct 11, 2019

BUY
$174.11 - $208.62 $108,992 - $130,596
626 Added 5.5%
12,007 $2.32 Million
Q2 2019

Jul 15, 2019

SELL
$166.7 - $195.41 $2,167 - $2,540
-13 Reduced 0.11%
11,381 $2.1 Million
Q1 2019

Apr 10, 2019

BUY
$180.87 - $203.88 $284,689 - $320,907
1,574 Added 16.03%
11,394 $2.16 Million
Q4 2018

Feb 07, 2019

BUY
$178.4 - $208.25 $187,320 - $218,662
1,050 Added 11.97%
9,820 $1.91 Million
Q3 2018

Oct 12, 2018

BUY
$185.29 - $208.89 $1.62 Million - $1.83 Million
8,770 New
8,770 $1.82 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Canton Hathaway, LLC Portfolio

Follow Canton Hathaway, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canton Hathaway, LLC with notifications on news.